Physician profile
Kenneth Ngo
NPI 1609097344
$4,058.26
in general payments reported to CMS, 2019-2025
15 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,280 · 2020: $406 · 2021: $1,287 · 2022: $236 · 2023: $280 · 2024: $411 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $557.14 | 2019-2020 | |
| Allergan, INC. | $518.55 | 2019-2021 | |
| Microtransponder, INC. | $446.40 | 2024-2025 | |
| Saol Therapeutics INC. | $337.30 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $330.99 | 2021-2024 | Xeomin |
| Neuronetics, INC. | $306.07 | 2021 | |
| Medtronic, INC. | $306.04 | 2021-2025 | Synchromedii |
| Abbvie INC. | $303.87 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $240.97 | 2019 | |
| Medtronic USA, INC. | $218.23 | 2019 | |
| Boston Scientific Corporation | $149.83 | 2019 | |
| Piramal Critical Care | $134.62 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $95.67 | 2019 | |
| Amneal Pharmaceuticals LLC | $68.46 | 2023 | Lyvispah, Lioresal (Baclofen) |
| Ambu INC. | $44.12 | 2020-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.